BRENDA SALGAR: Open Payments
NPI 1659049914 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 18 payments from 7 companies in 2025. Trend: 2023 $1,129 · 2024 $229 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $159 |
| UCB, Inc. | 3 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| SCPHARMACEUTICALS INC. | 2 | $43 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $38 |
| Amgen Inc. | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
Products named: ADVANTIO, Rystiggo, LEQVIO, FUROSCIX, LifeVest, ALTRUA 20, WATCHMAN FLX, REPATHA.
Industry payments across TX — which companies pay providers there.
